Leap Therapeutics Presents Data from Phase 1 Study of GITR Agonist

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. SPY
3. LCID
4. JPM
5. ERAS
6. BAC
7. TREX
8. AAPL
9. ORCL
10. SKHY

Go back to Leap Therapeutics Presents Data from Phase 1 Study of GITR Agonist
(NASDAQ: MCUR) Delayed: 1.51 --0 (-0%)
Previous Close $1.51    52 Week High $3.20 
Open $32.00    52 Week Low $0.75 
Day High $1.51    P/E N/A 
Day Low $1.51    EPS $0.00 
Volume 311,220